Davide Pareyson

14.1k total citations
252 papers, 7.9k citations indexed

About

Davide Pareyson is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Davide Pareyson has authored 252 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Cellular and Molecular Neuroscience, 113 papers in Neurology and 82 papers in Molecular Biology. Recurrent topics in Davide Pareyson's work include Hereditary Neurological Disorders (148 papers), Genetic Neurodegenerative Diseases (76 papers) and Botulinum Toxin and Related Neurological Disorders (58 papers). Davide Pareyson is often cited by papers focused on Hereditary Neurological Disorders (148 papers), Genetic Neurodegenerative Diseases (76 papers) and Botulinum Toxin and Related Neurological Disorders (58 papers). Davide Pareyson collaborates with scholars based in Italy, United States and United Kingdom. Davide Pareyson's co-authors include Chiara Marchesi, Angelo Sghirlanzoni, Giuseppe Lauria, Mary M. Reilly, Michela Morbin, Matilde Laurá, Paola Saveri, Ettore Salsano, Giuseppe Piscosquito and Franco Taroni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Brain.

In The Last Decade

Davide Pareyson

243 papers receiving 7.8k citations

Peers

Countries citing papers authored by Davide Pareyson

Since Specialization

Citations

This map shows the geographic impact of Davide Pareyson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Pareyson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Pareyson more than expected).

Fields of papers citing papers by Davide Pareyson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Pareyson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Pareyson. The network helps show where Davide Pareyson may publish in the future.

Co-authorship network of co-authors of Davide Pareyson

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Pareyson. A scholar is included among the top collaborators of Davide Pareyson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Pareyson. Davide Pareyson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Split Hand Syndrome in Charcot–Marie–Tooth Disease Type X1 (CMTX1): A Clinical, Neurophysiological, and Radiological Study 2025 ·European Journal of Neurology ·(unknown), Marco Moscatelli, (unknown), (unknown), (unknown), (unknown), Marina Grisoli, Paola Lanteri, Davide Pareyson, Chiara Pisciotta, (unknown)	0
2	Transthyretin amyloid deposition in the ligamentum flavum of an Italian cohort of patients with lumbar spinal stenosis 2025 ·Neurological Sciences ·(unknown), (unknown), Alessandro Izzo, Nicola Montano, Filippo Maria Polli, Alessandro Rapisarda, (unknown), Marco Schiariti, (unknown), Gianluca Marucci, Giorgio Giaccone, (unknown), Valeria Guglielmino, Ângela Romano, Davide Pareyson, Marco Luigetti	0
3	Charcot-Marie-Tooth disease: a review of clinical developments and its management - What’s new in 2025? 2025 ·Expert Review of Neurotherapeutics ·(unknown), (unknown), Paola Saveri, Chiara Pisciotta, Davide Pareyson	1
4	Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version 2024 ·Journal of the Peripheral Nervous System ·Federica Rachele Danti, Emanuela Pagliano, Davide Pareyson, Maria Foscan, (unknown), (unknown), (unknown), Giuseppe Piscosquito, (unknown), Sindhu Ramchandren, Isabella Moroni, Tong Wu	0
5	Clinical Characteristics of Charcot-Marie-Tooth Disease Type 4J 2024 ·Neurology ·Reza Sadjadi, Vincent Picher‐Martel, Jasper M. Morrow, Daniel R. Thedens, (unknown), Brett A. McCray, Davide Pareyson, D. Herrmann, Mary M. Reilly, Jun Li, Diana Castro, Michael E. Shy	2
6	Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure 2024 ·Neurology ·Melissa R. Mandarakas, Katy Eichinger, Paula Bray, Kayla Cornett, Michael E. Shy, Mary M. Reilly, Gita Ramdharry, Steven S. Scherer, Davide Pareyson, (unknown), Marnee J. McKay, (unknown), D. Herrmann, Joshua Burns	4
7	Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease 2023 ·Neurology ·(unknown), Kayla Cornett, Sarah P. Garnett, Rosemary Shy, (unknown), Sabrina W. Yum, Kimberly M. Anderson, Davide Pareyson, Isabella Moroni, Francesco Muntoni, Mary M. Reilly, Richard S. Finkel, David N. Herrmann, Katy Eichinger, Michael E. Shy, Joshua Burns, Manoj P. Menezes	3
8	Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural history 2023 ·Brain ·(unknown), Tong Wu, (unknown), Davide Pareyson, Richard A. Lewis, Sabrina W. Yum, Brett A. McCray, Sindhu Ramchandren, Joshua Burns, Jun Li, Richard S. Finkel, Steven S. Scherer, Stephan Züchner, Michael E. Shy, Mary M. Reilly, David N. Herrmann	10
9	Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints 2023 ·Annals of Neurology ·Mary M. Reilly, David N. Herrmann, Davide Pareyson, Steven S. Scherer, Richard S. Finkel, Stephan Züchner, Joshua Burns, Michael E. Shy	12
10	Validation of the Italian version of the pediatric CMT quality of life outcome measure 2022 ·Journal of the Peripheral Nervous System ·Isabella Moroni, Federica Rachele Danti, Davide Pareyson, Emanuela Pagliano, Giuseppe Piscosquito, Maria Foscan, (unknown), Anna Ardissone, S. Genitrini, Tong Wu, Michael E. Shy, Sindhu Ramchandren	4
11	Autophagy and Lysosomal Functionality in CMT2B Fibroblasts Carrying the RAB7K126R Mutation 2022 ·Cells ·Roberta Romanò, (unknown), Paola Saveri, Ilaria Elena Palamà, Chiara Pisciotta, Davide Pareyson, Cecilia Bucci, Flora Guerra	14
12	Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future Perspectives 2021 ·Brain Sciences ·Chiara Pisciotta, Paola Saveri, Davide Pareyson	37
13	Charcot–Marie–Tooth disease type 2F associated with biallelic HSPB1 mutations 2021 ·Annals of Clinical and Translational Neurology ·Elena Abati, Stefania Magri, Megi Meneri, (unknown), Daniele Velardo, (unknown), Chiara Pisciotta, Paola Saveri, Nereo Bresolin, Giacomo P. Comi, Dario Ronchi, Davide Pareyson, Franco Taroni, Stefania Corti	6
14	Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy 2021 ·Proceedings of the National Academy of Sciences ·Marta Guerrero‐Valero, (unknown), Silvia Cipriani, (unknown), (unknown), Gaëtan Chicanne, (unknown), Francesca Bianchi, Ubaldo Del Carro, Ivan de Curtis, Davide Pareyson, Yeşim Parman, Angelo Schenone, Volker Haucke, Bernard Payrastre, Alessandra Bolino	19
15	Validation of the Italian version of the Charcot‐Marie‐Tooth Health Index 2020 ·Journal of the Peripheral Nervous System ·Chiara Pisciotta, Emma Ciafaloni, Riccardo Zuccarino, Daniela Calabrese, Paola Saveri, Silvia Fenu, Irene Tramacere, Filippo Genovese, Nuran Dilek, Nicholas E. Johnson, Chad Heatwole, David N. Herrmann, Davide Pareyson, (unknown)	3
16	Reliability of the Charcot‐Marie‐Tooth functional outcome measure 2020 ·Journal of the Peripheral Nervous System ·Paula Bray, Kayla Cornett, (unknown), Davide Pareyson, Riccardo Zuccarino, Mariola Skorupinska, Menelaos Pipis, Janet E. Sowden, Steven S. Scherer, Mary M. Reilly, Michael E. Shy, David N. Herrmann, Joshua Burns, Katy Eichinger	9
17	Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS 2020 ·Annals of Clinical and Translational Neurology ·Kayla Cornett, Manoj P. Menezes, Paula Bray, Rosemary Shy, Isabella Moroni, Emanuela Pagliano, Davide Pareyson, Tim Estilow, Sabrina W. Yum, (unknown), Francesco Muntoni, Matilde Laurá, Mary M. Reilly, Richard S. Finkel, Katy Eichinger, David N. Herrmann, Michael E. Shy, Joshua Burns, (unknown)	15
18	The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage 2018 ·Orphanet Journal of Rare Diseases ·Anna Ambrosini, Daniela Calabrese, (unknown), (unknown), Guido Cavaletti, Maria Carmela Pera, António Toscano, Giuseppe Vita, Lucía Monaco, Davide Pareyson	24
19	CSF and Blood Levels of GFAP in Alexander Disease 2015 ·eNeuro ·(unknown), Guillermo Agosta, William Benko, Jens C. Eickhoff, Stephanie Keller, Wolfgang Köehler, David M. Koeller, Soe Mar, Sakkubai Naidu, Jayne Ness, Davide Pareyson, Deborah L. Renaud, Ettore Salsano, Raphael Schiffmann, Julie Simon, Adeline Vanderver, Florian Eichler, Marjo S. van der Knaap, Albee Messing	31
20	Autosomal dominant cerebellar ataxias: Genotype frequency and clinical/molecular correlations 1997 ·The Italian Journal of Neurological Sciences ·Davide Pareyson, Cinzia Gellera, Barbara Castellotti, (unknown), (unknown), (unknown), F. Girotti, Caterina Mariotti, Stefano DiDonato	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact